Treatment with interferon-alpha (IFNα) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFNα-induced depressive and anxiety symptoms and immune activation

This publication has 26 references indexed in Scilit:

• Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy
  Neuropsychopharmacology, 2001
• Psychological and behavioural effects of interferons
  Current Opinion in Psychiatry, 2000
• Effect of single intracerebroventricular injection of α-interferon on monoamine concentrations in the rat brain
  European Neuropsychopharmacology, 2000
• Dipeptidyl peptidase IV and adenosine deaminase activity: Decrease in depression
  Psychoneuroendocrinology, 1999
• Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: Relationships with immune-inflammatory markers
  Psychoneuroendocrinology, 1997
• Lower Serum L-Tryptophan Availability in Depression as a Marker of a More Generalized Disorder in Protein Metabolism
  Neuropsychopharmacology, 1996
• Fetal osteocalcin levels are related to placental 11β‐hydroxysteroid dehydrogenase activity in humans
  Clinical Endocrinology, 1995
• Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13
  Clinical and Experimental Immunology, 1995
• Mechanisms of the Behavioral Effects of Interleukin 1 Role of Prostaglandins and CRFa
  Annals of the New York Academy of Sciences, 1992
• A New Depression Scale Designed to be Sensitive to Change
  The British Journal of Psychiatry, 1979